BindingDB logo
myBDB logout

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23134659 74 Design and synthesis of procollagen C-proteinase inhibitors.EBI FibroGen Inc.
11514144 51 Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues.EBI Roche Bioscience
18945617 50 Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: design, synthesis, and evaluation as topically applied, dermal anti-scarring agents.EBI Pfizer Global Research and Development
18790648 317 Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.EBI University of Athens
17591762 102 Potent and selective nonpeptidic inhibitors of procollagen C-proteinase.EBI Pfizer Global Research and Development
12877590 28 A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.EBI Pfizer Global Research and Development
12824039 56 Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.EBI CombiChem Inc.
12798313 19 Novel inhibitors of procollagen C-terminal proteinase. Part 1: diamino Acid hydroxamates.EBI CombiChem Inc.
11934595 80 Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase. Part 2: Solid-phase optimization of side chains.EBI Roche Bioscience
11086718 65 Solid-phase synthesis of di- and tripeptidic hydroxamic acids as inhibitors of procollagen C-proteinase.EBI Roche Bioscience